Herceptin is for intravenous infusion only. Do not administer as an intravenous push or bolus. Herceptin has different dosage and administration instructions than subcutaneous trastuzumab products. Do not mix Herceptin with other drugs. Do not substitute Herceptin (trastuzumab) for or with ado-trastuzumab emtansine or fam-trastuzumab deruxtecan.
by AM Feldman 2024 Cited by 198Trastuzumab (Herceptin) is a monoclonal antibody that In addition, although the warning in the package insert suggests that trastuzumab
preparation of KANJINTI, refer to the package insert or call Herceptin (trastuzumab) Prescribing Information [revised 2024], Genentech.
To define and describe the accepted indications for Trastuzumab products [Herceptin (trastuzumab), Please refer to the FDA label/package insert for details
Herceptin. Package insert. Genentech Inc; 2024. 2. Herzuma. Package insert. Celltrion Inc; 2024. 3. Kanjinti. Package insert. Amgen Inc
Side Effect Videos Nausea and Vomiting Diarrhea Fatigue Pain Anemia See DailyMed package insert. Trastuzumab (Herceptin
Herceptin [package insert]. South San Francisco, CA: Genentech, Inc.; April 2024. 2. Ogivri [package insert]. Zurich, Switzerland: Mylan GmbH; December 2024
Herceptin should be administered by a qualified health care professional. It is important to check the product labels to ensure that the correct formulation (Herceptin IV or Herceptin SC) is being administered to the patient as prescribed. Switching treatment between Herceptin IV and Herceptin SC and vice versa, using
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg. References. 1. Herceptin [package insert]. Genentech, Inc, South San Francisco, CA. Available at
Comments